AT

Atara Biotherapeutics

- NASDAQ:ATRA
For additional historical data visit
thinknum.com/demo

Job Listings

Request demo
# Ticker Symbol Entity Name Domain As Of Date Title URL Brand Category Location Text City State Country Posted Date Number of Openings Description Date Added Date Updated Ticker Sector Ticker Industry
1 nasdaq:atra www.atarabio.com www.atarabio.com Apr 15th, 2019 12:00AM Medical Director Clinical Sciences - Neuroscience Open Clinical Science Thousand Oaks, CA, United States Thousand Oaks CA USA Mar 18th, 2019 12:00AM Position Summary This role is responsible for providing expert medical input to human clinical trials for Atara Bio products under development for multiple sclerosis and other conditions. The incumbent has hands-on responsibility for designing clinical trials to evaluate the efficacy, safety, clinical pharmacology, and pharmacokinetics of cellular immunotherapies, and also managing scientific collaborations with pre-eminent academic institutions and consultants.  As with all of our clinicians, interested candidates should have an interest and passion for work in all aspects of clinical drug development. Location        Thousand Oaks (northwest Los Angeles area), CA or South                               San Francisco, CAReports to     Senior Director, Clinical Sciences Primary ResponsibilitiesDesigns and optimizes multiple sclerosis therapy clinical trials, including development of clinical protocols and amendments, investigator brochures, annual reports, abstracts, manuscripts and clinical study reports in collaboration with the clinical development team.Serves as a medical monitor, including evaluation of the safety, pharmacology, and efficacy in ongoing and completed studies in close collaboration with the clinical operations team.Establishes and implements exploratory pharmacodynamic, predictive and prognostic biomarker plans in conjunction with staff, consultants and collaborators.Interacts with study investigators, thought leaders, including advisory boards, academicians, and internal colleagues.Ensures adherence to Atara Bio Standard Operating Procedure (SOP) standards.Maintains clinical and scientific awareness in area of expertise. Travel-  Travel may be required (up to 25%). Physical Requirements Subject to extended periods of sitting and/or standing, vision to monitor and moderate noise levels. Work is generally performed in an office or clinical environment. Car and airplane (see above) travel is an essential part of the job. Professional Qualifications or M.D., Ph.D. with advanced training or significant experience in multiple sclerosis.  Board certification is preferred.Demonstrated understanding of the drug development process.Knowledge of Good Clinical Practices (GCP), FDA regulations and guidelines, and applicable regulatory requirements.Ability to effectively evaluate outside expert advice.Ability to communicate and explain medical issues to clinical, regulatory, biomarker, biostatistics, data management and manufacturing colleagues who may have a non-medical background.Ability to manage and direct work independently as well as work effectively in Atara’s team-based environment.Experience working effectively in a fast-paced, team-based environment. Personal QualificationsStrong leadership skills with an ability to set a vision, to lead change, and to lead and mentor others.Ability to create and communicate a compelling sense of core purpose and ability to solicit opportunities and possibilities.Ability to organize, structure and staff the organization in a rapidly changing environment.Strong personal presence with ability to command respect through exercise of sound business judgment and clear decision-making.Forward thinker with strong industry knowledge and an ability to identify, synthesize and act upon strategic information and changes within the environment.Demonstrates a passion for and focus on results with an ability to create excitement and a sense of purpose. More About Atara BioNow in our sixth year, we’re proud of our team of 260+ Atarians co-located by design in South San Francisco (corporate headquarters) and Southern California (R&D and manufacturing headquarters in the northwest Los Angeles area) with a newly-established European headquarters in Zug, Switzerland. Atara also has a R&D site in the Denver, Colorado area and an office in New York City. Our Southern California hub is anchored by a new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California.One mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork and expertise” – and a singular vision – “Cell therapy treatment for every patient, any time – provide inspiration and direction for all of us.”The Company's off-the-shelf, allogeneic T-cells are bioengineered from donors with healthy immune function and allow for rapid delivery from inventory to patients without a requirement for pretreatment. Atara's T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells.Atara's most advanced T-cell immunotherapy in development, tabelecleucel, or tab-cel™ (formerly known as ATA129), is being developed for the treatment of patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+ PTLD) who have failed rituximab, as well as other EBV-associated hematologic and solid tumors, including nasopharyngeal carcinoma (NPC). Tab-cel™ is in Phase 3 clinical development for the treatment of EBV+ PTLD following an allogeneic hematopoietic cell transplant (MATCH study) or solid organ transplant (ALLELE study).Atara is also developing off-the-shelf, allogeneic ATA188 and autologous ATA190 T-cell immunotherapies using a complementary targeted antigen recognition technology for specific EBV antigens believed to be important for the potential treatment of multiple sclerosis (MS). A Phase 1 clinical study of autologous ATA190 in patients with progressive MS is ongoing. Atara is also advancing a Phase 1 clinical study of ATA188 in patients with progressive or relapsing-remitting MS across clinical sites in the United States and Australia. Atara's clinical pipeline also includes ATA520 targeting Wilms Tumor 1 (WT1) and ATA230 directed against cytomegalovirus (CMV).Working at Atara BioPeople at Atara Bio are high integrity, roll-up-your-sleeves, get-it-done types who are keenly committed to putting patients first, advancing medical care and doing so with demonstrated urgency. At their core Atarians are people who work well with others and are “team-centric”, have purposeful curiosity and can’t wait to save patient lives. And similar to other biotech companies who have so many accomplished people, we expect humility (we are a “low hubris” sort of place), flexibility, respect, teamwork, good judgment and getting the most out of any dollar we spend. We also expect to enjoy the journey (and each other) as we move forward with a shared responsibility to teach and to learn from what we do and from our teammates.Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual’s association with a member of a protected group or connection to an organization or group related to a protected group.We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States. Apr 14th, 2019 11:12PM Apr 14th, 2019 11:12PM Health Care Pharmaceuticals & Biotechnology
2 nasdaq:atra www.atarabio.com www.atarabio.com Apr 15th, 2019 12:00AM Senior Scientist - Viral Vector Process Development Open Process Sciences Thousand Oaks, CA, United States Thousand Oaks CA USA Jan 14th, 2019 12:00AM Position Summary: The Viral Vector Process Development Senior Scientist / Scientist is a part of a growing Virology Team and is responsible for viral vector process and analytical development supporting Atara’s T-cell therapy programs. This role is responsible for designing and implementing viral vector strategies for upstream and downstream process development. This position works closely with external contract laboratories on viral vector studies to support external manufacturing. The person also transfers viral processes and assays in-house and performs laboratory studies.This position includes master and working cell bank and viral seed stock production, viral vector production and purification, virus process development and scale-up, development of in-process controls and virus analytical methods to support manufacturing and lot release, managing experimental plans and schedules, experimental design, statistical data analysis, and interpretation. This role authors technical protocols and reports, drafts batch records and SOPs. The position also reviews regulatory filings, including specifications, validation, comparability, trend analysis, risk assessment, and product quality attributes. The role interacts cross-functionally within the process sciences and analytical organizations, as well as with other departments (regulatory, quality, manufacturing, clinical, supply chain) supporting IND and Marketing Application filings.The candidate should have successfully demonstrated viral vector process development, production, and analytics, as well as personal attributes including initiative, independent thinking and collaboration skills.Reporting Relationship and Work Location: This position, based in Thousand Oaks (NW Los Angeles area), CA Reports to the Associate Director, Viral Vector Process and Analytics.  Primary Responsibilities:Designs and implements viral vector strategies for upstream and downstream process developmentWorks closely with external partners on appropriate viral vector process and characterization studies to enable manufacturingTransfers and executes viral vector laboratory procedures and assays in-house as requiredAuthors and reviews viral vector development and process protocols, reports, and batch recordsSupports virus analytical method development, qualification, transfer, and associated protocols/reports as neededAssists with viral vector product quality attribute assessment and scoring to identify critical quality attributes (CQA)Supports viral vector process and analytical sections for regulatory filings and response to questionsSkills and Abilities:Experience with viral vector production, purification, and characterizationStrong communication skills (e.g., clear and concise) and a team playerStrong time and project management skillsStrong critical and logical thinking with ability to analyze problems, identify alternative solutions, and implement recommendations for resolutionSelf-motivated and flexible, able to prioritize, multi-task, and work in a fast-paced & demanding environmentTakes ownership of the assigned project, consulting with management and peersAble to understand and interpret data/information and its practical application Education and ExperienceRequiredPhD in virology, virus bioengineering, or gene/cell therapy with 5+ years of industry-related experience; or Master’s Degree with 10+ years of related industry experience; or Bachelor’s Degree with 15+ years of experience.Knowledge and experience in viral vector production, purification, and analyticsProficient with large-scale mammalian cell culture and suspension cellsAbility to design experiments, follow procedures with attention to detail, and successfully execute experiments at the benchProject-management skills and ability to work successfully with contracting laboratories and manufacturing facilitiesComfortable in a fast-paced small company environment with minimal direction and able to adjust workload based upon changing prioritiesDemonstrated ability to maintain detailed execution records and perform data analysis PreferredExperience with adenoviral vector a strong benefitExperience desired with retroviral and/or lentiviral vectorsKnowledge or experience with viral vector manufacturing in the biotech industryExpertise in virus upstream and downstream process development, such as large-scale suspension cell culture, bioreactors, tangential flow filtration, column purificationExperience with Design of Experiment (DOE)Experience with virus characterization, such as replication-competent virus (RCV), infectious virus bioassays and viral particle assays Travel:Ability to travel up to 10%Physical Requirements Subject to extended periods of sitting and standing, vision to monitor and moderate noise levels. Work is approximately 50% lab based and 50% office based. More About Atara Bio Now in our sixth year, we’re proud of our team of 260+ Atarians co-located by design in South San Francisco (corporate headquarters) and Southern California (R&D and manufacturing headquarters in the northwest Los Angeles area) with a newly-established European headquarters in Zug, Switzerland. Atara also has a R&D site in the Denver, Colorado area and an office in New York City. Our Southern California hub is anchored by a new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California.One mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork and expertise” – and a singular vision – “Cell therapy treatment for every patient, any time – provide inspiration and direction for all of us.”The Company's off-the-shelf, allogeneic T-cells are bioengineered from donors with healthy immune function and allow for rapid delivery from inventory to patients without a requirement for pretreatment. Atara's T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells.Atara's most advanced T-cell immunotherapy in development, tabelecleucel, or tab-cel™ (formerly known as ATA129), is being developed for the treatment of patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+ PTLD) who have failed rituximab, as well as other EBV-associated hematologic and solid tumors, including nasopharyngeal carcinoma (NPC). Tab-cel™ is in Phase 3 clinical development for the treatment of EBV+ PTLD following an allogeneic hematopoietic cell transplant (MATCH study) or solid organ transplant (ALLELE study).Atara is also developing off-the-shelf, allogeneic ATA188 and autologous ATA190 T-cell immunotherapies using a complementary targeted antigen recognition technology for specific EBV antigens believed to be important for the potential treatment of multiple sclerosis (MS). A Phase 1 clinical study of autologous ATA190 in patients with progressive MS is ongoing. Atara is also advancing a Phase 1 clinical study of ATA188 in patients with progressive or relapsing-remitting MS across clinical sites in the United States and Australia. Atara's clinical pipeline also includes ATA520 targeting Wilms Tumor 1 (WT1) and ATA230 directed against cytomegalovirus (CMV).Working at Atara Bio People at Atara Bio are high integrity, roll-up-your-sleeves, get-it-done types who are keenly committed to putting patients first, advancing medical care and doing so with demonstrated urgency. At their core Atarians are people who work well with others and are “team-centric”, have purposeful curiosity and can’t wait to save patient lives. And similar to other biotech companies who have so many accomplished people, we expect humility (we are a “low hubris” sort of place), flexibility, respect, teamwork, good judgment and getting the most out of any dollar we spend. We also expect to enjoy the journey (and each other) as we move forward with a shared responsibility to teach and to learn from what we do and from our teammates.Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual’s association with a member of a protected group or connection to an organization or group related to a protected group.We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States. Apr 14th, 2019 11:12PM Apr 14th, 2019 11:12PM Health Care Pharmaceuticals & Biotechnology
3 nasdaq:atra www.atarabio.com www.atarabio.com Apr 15th, 2019 12:00AM Senior Manager/Associate Director - Global Market Analytics Open Commercial South San Francisco, CA, United States South San Francisco CA USA Apr 3rd, 2019 12:00AM Position Summary:This role provides leadership for global market research, revenue forecasting, and commercial analytics for Atara Bio’s portfolio of products up to and including ATA188/190, CAR-T programs as well as the pipeline.Position Responsibilities:Creates, manages, validates, and refines global revenue forecasts in collaboration with the extended commercial organization.Develops and implements global market research plans/activities in key customer segments such as providers, payers, patients, and customer experience with Atara Product Delivery System, etc.Develops and maintains the short and long-term global forecasts for commercial (extensive experience developing forecast model and forecast scenarios) and launch window products. Aligns our product supply & demand needs globally.Supports global portfolio planning by providing insights that enable selection of product candidates as well as development and commercialization strategies for pipeline products.Develops forecast models, revenue forecasts and insights to support evaluation of business development and partnership opportunities. Provide commercial recommendations on business development opportunities.Supports the creation and implementation of core business intelligence operational processes such as development of dashboards to track performance and marketing programsDevelops data-driven insights, opinions and recommendations to drive the business forward in a measurable way.Drives the use of the leading tools and techniques in Market Research, Competitive Intelligence, Forecasting and Analytics.Responds flexibly and adaptively to the needs of the organization through a culture of continuous improvement and innovation.Delivers unique and compelling insights and ideas on our brands, markets and stakeholders through market research excellence, innovation and story telling using graphicsProvides input into strategic plans and other key business documents/questions.Travel:  Travel Required (up to 30%) Physical Requirements:  Subject to extended periods of sitting and/or standing, vision to monitor and moderate noise levels. Work is generally performed in an office or clinical environment. Car and airplane (see travel above) travel is an essential part of the job.Position Requirements:Extensive commercial analytics experience, including but limited to primary market research, secondary market research, forecasting, sales operations & analytics, market access analytics.Extensive experience applying market insights to launch strategy, tactical planning and launch tracking.Significant experience developing forecast models, scenarios.Wonderful story telling using graphicsSolid business acumen and strategic agility driven by solid analytical thinking.Excellent communication and presentation skills.Proven ability to influence without authority.Committed to the values of integrity, accountability, transparency, scientific rigor and drive.PhD and/or MS/MBA in healthcare related field preferred.  BS/BA degree required.6 or more years of relevant competitive intelligence experience within the Life Sciences or Healthcare industries.A strong familiarity with clinical drug development, tumor/cancer biology and neuroscience will be important assets for this position.Role model for Atara Biotherapeutics’ values. More About Atara BioNow in our sixth year, we’re proud of our team of 300+ Atarians co-located by design in South San Francisco (corporate headquarters) and Southern California (R&D and manufacturing headquarters in the northwest Los Angeles area) with a newly-established European headquarters in Zug, Switzerland. Atara also has a R&D site in the Denver, Colorado area and an office in New York City. Our Southern California hub is anchored by a new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California.One mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork and expertise” – and a singular vision – “Cell therapy treatment for every patient, any time – provide inspiration and direction for all of us.”The Company's off-the-shelf, allogeneic T-cells are bioengineered from donors with healthy immune function and allow for rapid delivery from inventory to patients without a requirement for pretreatment. Atara's T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells.Atara's most advanced T-cell immunotherapy in development, tabelecleucel, or tab-cel™ (formerly known as ATA129), is being developed for the treatment of patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+ PTLD) who have failed rituximab, as well as other EBV-associated hematologic and solid tumors, including nasopharyngeal carcinoma (NPC). Tab-cel™ is in Phase 3 clinical development for the treatment of EBV+ PTLD following an allogeneic hematopoietic cell transplant (MATCH study) or solid organ transplant (ALLELE study).Atara is also developing off-the-shelf, allogeneic ATA188 and autologous ATA190 T-cell immunotherapies using a complementary targeted antigen recognition technology for specific EBV antigens believed to be important for the potential treatment of multiple sclerosis (MS). A Phase 1 clinical study of autologous ATA190 in patients with progressive MS is ongoing. Atara is also advancing a Phase 1 clinical study of ATA188 in patients with progressive or relapsing-remitting MS across clinical sites in the United States and Australia. Atara's clinical pipeline also includes ATA520 targeting Wilms Tumor 1 (WT1) and ATA230 directed against cytomegalovirus (CMV). Working at Atara BioPeople at Atara Bio are high integrity, roll-up-your-sleeves, get-it-done types who are keenly committed to putting patients first, advancing medical care and doing so with demonstrated urgency. At their core Atarians are people who work well with others and are “team-centric”, have purposeful curiosity and can’t wait to save patient lives. And similar to other biotech companies who have so many accomplished people, we expect humility (we are a “low hubris” sort of place), flexibility, respect, teamwork, good judgment and getting the most out of any dollar we spend. We also expect to enjoy the journey (and each other) as we move forward with a shared responsibility to teach and to learn from what we do and from our teammates. Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual’s association with a member of a protected group or connection to an organization or group related to a protected group.We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States. Apr 14th, 2019 11:12PM Apr 14th, 2019 11:12PM Health Care Pharmaceuticals & Biotechnology
4 nasdaq:atra www.atarabio.com www.atarabio.com Apr 15th, 2019 12:00AM Director Next Generation CAR-T (off-the-shelf), Clinical R&D Open Research & Development Thousand Oaks, CA, United States Thousand Oaks CA USA Oct 10th, 2018 12:00AM Position Summary:    We are looking for a board-certified medical oncologist/hematologist/infectious disease/rheumatologist with immunotherapy experience to provide medical and scientific leadership to our engineered T cell programs. Atara is building engineered CAR T cells that target Acute Myelogenous Leukemia, B cell malignancies, solid tumors, infectious disease and autoimmune disease, taking advantage of our experience with off-the-shelf viral T cells to revolutionize access and speed to treatment for patients. Novel CAR signaling domains derived from scientific collaborations will be integrated from pre-eminent academic institutions that promise to improve T cell persistence and potency.  In addition, our solid tumor targeting CARs incorporate checkpoint inhibition to overcome the immunosuppressive tumor cell microenvironment.   The Director will be responsible for designing and monitoring clinical trials to evaluate the efficacy, safety, kinetics of T cell expansion, and biomarker program for CAR T product candidates working together with internal and external regulatory colleagues.  He/she will manage clinical and scientific collaborations with academic pioneers and consultants, will participate in regulatory interactions to support IND submission and clinical development in a fast-paced environment, and will gain experience in business development and product assessment. The Director must have an excellent immunotherapy scientific knowledge base to operationalize the CAR T programs. Reports to:   EVP, Chief Scientific OfficerLocation:      Westlake Village, CA.Primary ResponsibilitiesContributes to design of immuno-oncology CAR T clinical trials, including literature review, development of clinical protocols and amendments, investigator brochures, annual reports, abstracts, manuscripts and clinical study reports in collaboration with the cross functional team and academic collaborators.Serves as a medical monitor, including evaluation of the safety, pharmacology and efficacy in ongoing and completed studies and advocates for the health and well-being of patients.As the medical lead of a study, responsible for ensuring data quality, summary and writing of clinical study reports in close collaboration with the clinical operations, biometrics and medical writing team.Works on IND, EOP2, BTD, BLA and equivalent international submission documents.Establishes and implements exploratory pharmacodynamic, predictive and prognostic biomarker plans in conjunction with staff, consultants and collaborators.Ensures adherence to Atara Bio’s Standard Operating Procedures. Travel- Travel is required (up to 25%).Physical Requirements Subject to extended periods of sitting and/or standing, vision to monitor and moderate noise levels. Work is generally performed in an office or clinical environment. Car and airplane (see above) travel is an essential part of the job. Professional QualificationsMinimum of an M.D. or M.D./Ph.D., and advanced training in hematology, oncology, infectious disease or rheumatology with immunology or similar experience preferred. Board certification is preferred.Experience designing, leading and managing clinical studies in solid tumors, hematologic malignancies and preferably immuno-oncology preferred.Knowledge of Good Clinical Practices, FDA regulations and guidelines and applicable regulatory requirements.Ability to explain immunologic and oncologic technical issues to clinical, regulatory, biomarker, biostatistics, data management and manufacturing colleagues who may have a non-medical background.Ability to work independently.Experience working effectively in a fast-paced, team-based environment.Strong clinical/scientific/technical skills.Ability to anticipate and resolve problems effectively.Strong verbal communication and technical writing skills.Ability to present clearly using scientific and clinical terminology.Strong interpersonal skills and the ability to communicate effectively with people in diverse and different settings.Sound organizational skills.Possesses sense of urgency; identifies challenges and problems and takes the initiative to identify solutions.Motivates team members; fosters and nurtures teamwork.Project management skills and focus on delivery of results.Role model for Atara’s values of patients first, innovation, teamwork, community and mindset. Apr 14th, 2019 11:12PM Apr 14th, 2019 11:12PM Health Care Pharmaceuticals & Biotechnology
5 nasdaq:atra www.atarabio.com www.atarabio.com Apr 15th, 2019 12:00AM Process Engineer Open Manufacturing Thousand Oaks, CA, United States Thousand Oaks CA USA Feb 22nd, 2019 12:00AM We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options to combat cancer and other serious illnesses. Our research is based on technology that enables the ability to harness and augment the immune system to stem disease. Our goal is to help patients, such as Atara Ciechanover, our company’s namesake, who suffered from cancer before passing away in 2012. We aim to empower patients to fight their illnesses with innovative treatment options.Position SummaryThe Process Engineer works as part of the Manufacturing team delivering on team goals to generating high quality materials that can be used both in the clinic as well as commercially. This position will contribute to the successful delivery of released product in support of clinical trials and commercial requirements. The Process Engineer will provide process development and engineering support for technology transfer, process equipment evaluation, process validation and GMP manufacturing for Atara’s cell therapy products along with providing technical oversight for fill/finish activities.Reports to:                           Sr. Manager, Process Engineering, Internal ManufacturingWork Location:                     Thousand Oaks, CATravel                Ability to travel up to 10% travel time.Physical Requirements Subject to extended periods of sitting and/or standing in a clean room environment (ISO 5).  Work is generally performed in the manufacturing clean room or development environment.Position Requirements:Evaluate process equipment specific to Atara’s cell therapy products and make recommendations to management.Participate in technology transfers of new technologies into GMP manufacturing operations.Act as owner’s representative and engineering lead on small to mid-size capital projects related to manufacturing expansion, process capability, and process improvement projects. Project management experience is a plus.Write documents pertaining to the operations for the companies lead products, EBV and CAR-T cells.Work with the quality group and contract manufacturing organization to support regulatory filings for the various clinical programs.Assist in the day to day operations for the manufacturing activities and identify improvement opportunities.Support development and technology transfer into the manufacturing department.Investigate problems and root cause analysis and implement solutions.Work with the process development team to improve process and demonstrate feasibility in the manufacturing environment.Strong communication skills (e.g., clear and concise), both written and verbal and a team player.Specific experience with ERP, MES, QMS, LIMS is a plus.Previous experience in evaluation of fill/ finish and/or cell therapy equipment and technology is a plus.Experience with computer and documentation systems.Good decision making with strong judgment through collaboration and consideration of others point-of-view.Ability to understand manufacturing process and equipment related engineering tools, such as process flow diagrams, and/or engineering specifications/requirements.Understands cGMP for cell therapy manufacturing.Flexibility to work on any shift required to accommodate the business needs.Must be able to work in controlled environments requiring special gowning. Will be required to follow gowning requirements and wear protective clothing over the head, face, hands, feet, and body.Education and Professional Experience:BS degree in field of biochemical/chemical/mechanical engineering or life sciences and 3-5 years related work experience.Equipment qualification experience in a cGMP environment (IQ, OQ, PQ) is preferred; process validation experience is a plus.Must be knowledgeable and have worked in biotech manufacturing related industry.Demonstrated understanding of cGMP execution.Supervisorial experience in a manufacturing environment preferred.More About Atara BioWe are a four-year-old approximately 100+ person publicly traded (NASDAQ exchange symbol ATRA) clinical-stage biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases that have been underserved by scientific innovation. We are co-located by design in Westlake Village, CA (northwest LA) and South San Francisco, CA, with a process development lab in the Denver, CO area at the Fitzsimons Innovation Center and an office in New York City.We are concentrating on developing allogeneic or third-party derived antigen-specific T-cells. T-cells are a type of white blood cell. Cytotoxic T-cells, otherwise known as cytotoxic T lymphocytes, or CTLs, can mount an immune response against an antigen or antigens to combat viral infection or disease.   Our most advanced T-cell product candidate, ATA129 (previously referred to as EBV-CTL), which is a third-party derived Epstein-Barr virus CTL, is currently being investigated for the treatment of Epstein-Barr virus, or EBV, associated post-transplant lymphoproliferative disorder, or EBV-PTLD. In immunocompromised patients, EBV causes lymphomas and other lymphoproliferative disorders, collectively called EBV-PTLD. EBV-PTLD most commonly affects patients after hematopoietic cell transplant, or HCT, or after solid organ transplant, or SOT.In December 2016, we announced that we had reached agreement with the U.S. Food and Drug Administration, or FDA, on the designs of two Phase 3 trials for ATA129 intended to support approval in two separate indications, the treatment of rituximab-refractory EBV-PTLD after HCT and after SOT.In February 2015, the FDA granted breakthrough therapy designation for ATA129 in the treatment of rituximab-refractory EBV-PTLD after HCT. Breakthrough therapy designation is an FDA process designed to accelerate the development and review of drugs intended to treat a serious condition when early trials show that the drug may be substantially better than current treatment. In February 2016, the FDA granted orphan drug designation for ATA129 for the treatment of patients with EBV-PTLD after HCT or SOT.  We are also pursing marketing approval of ATA129 in the European Union, or EU.  In March 2016, the European Medicines Agency, or EMA, issued a positive opinion for orphan drug designation for ATA129 for the treatment of patients with EBV-PTLD.  In October 2016, the EMA Committee for Medicinal Products for Human Use, or CHMP, and Committee for Advanced Therapies, or CAT, granted access to the EMA’s newly established Priority Medicines, or PRIME, regulatory initiative for ATA129 for the treatment of patients with rituximab refractory EBV-PTLD following HCT.  PRIME provides early enhanced regulatory support to facilitate regulatory applications and accelerate the review of medicines that address a high unmet need.  In January 2017, we announced that pursuant to parallel scientific advice from the EMA’s Scientific Advice Working Group and several national Health Technology Assessment, or HTA, agencies in the EU, in 2018 we plan to submit an application for Conditional Marketing Authorization, or CMA, of ATA129 in the treatment of patients with rituximab refractory EBV-PTLD following HCT.In addition to ATA 129, Atara Bio is in the process of bringing forward three other t-cell product candidates (ATA188, ATA520, ATA230 for indications ranging from Multiple Myeloma to Nasopharyngeal carcinoma to Multiple Sclerosis) that are in various trials.Working at Atara BioPeople at Atara Bio are high integrity, get-it-done, roll-up-your-sleeves types who are keenly committed to putting patients first, advancing medical care and doing so with demonstrated urgency. With many accomplished people at Atara Bio, we expect humility, flexibility, respect, teamwork, good judgment and getting the most out of any dollar we spend. We also expect to enjoy the journey (and each other) as we move forward with a responsibility to teach and to learn from each other.Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual’s association with a member of a protected group or connection to an organization or group related to a protected group.We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States. Apr 14th, 2019 11:12PM Apr 14th, 2019 11:12PM Health Care Pharmaceuticals & Biotechnology
6 nasdaq:atra www.atarabio.com www.atarabio.com Apr 15th, 2019 12:00AM Senior Manager External Manufacturing Open Technical Operations & Supply Chain Thousand Oaks, CA, United States Thousand Oaks CA USA Mar 29th, 2019 12:00AM We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options. We’re named after Atara Ciechanover who suffered from cancer before passing away. We are considered a leading off-the-shelf T-cell immunotherapy company (Nasdaq ATRA) developing novel treatments for patients with cancer, autoimmune and viral diseases.Position Summary: The External Manufacturing team is focused on enabling and ensuring cGMP compliant cell therapy manufacturing within Atara’s external network to enable commercialization of Atara’s pipeline. This role is responsible for operational activities including manufacturing, manufacturing readiness, technology transfer, contract negotiation and management, budgeting, project planning, metrics, establishing joint KPIs and leading a cross-functional team working with contract manufacturing organizations (CMOs) and manufacturing partners producing and/or testing Atara products, key raw materials and intermediates.Understands and leverages industry knowledge regarding CMO capabilities, performance, price-points and technology advancements to best enable Atara’s planning and execution of its product pipeline.Leads and manages day to day operations of a cross functional project teams.Leads on-the-floor manufacturing activities including production readiness, materials management, validation readiness, and document readiness.Supports and/or leads deviation investigations, change controls and CAPAs.Develops integrated project plans and utilizes them to identify rate limiting factors, key dependencies and opportunities for program advancement. Acts as cross-functional liaison to ensure project plans remain aligned with current business development strategies.Develops KPIs and tracking dashboards to identify critical issues that can impact program delivery.Develops data-driven insights, opinions and recommendations to drive the business forward in a measurable way.Responds flexibly and adaptively to the needs of the organization through a culture of continuous improvement and innovation.Provides input into strategic plans and other key business documents/questions.Responsible for timely identification of critical path risks and for escalating issues to line leaders and project team representative for resolution.Ensures all team members understand project goals and objectives, current project plan and schedule, critical path activities and risks.Applies decision analysis tools to analyze complex situations (especially those involving external manufacturers and partners) and recommend defensible actions and solutions.Proactively provides strong scientific leadership and hands-on support for all aspects of quality, technology transfer, process scale-up, process monitoring and troubleshooting of manufacturing activities.Partners with Plant Manager, Quality Site Head, Manufacturing, Supply Chain, Logistics Coordinators and Engineering leaders to assure timely facility qualification and licensure.Champions operational excellence and recommends and implements innovative process ideas that impact execution and cost efficiency.Fosters cross-functional working relationships with internal and external groups, lead interactions between Atara Process Sciences, Quality Assurance, Supply Chain and Project Leadership and external manufacturing entities to ensure successful development of all products.As a key interface between different groups, ensures timely communication of changes or updates on timelines and deliverables.Provides support for regulatory submissions related to products manufactured at the manufacturing sites for which this role has accountability.Builds and maintains relationships with key personnel, both internally and with external parties.Role model for Atara’s Values of patients first, innovation teamwork, community and mindset.Effectively interfaces with other line functions (e.g. Regulatory Affairs, Commercial, etc.) and function autonomously as a Product Development Project LeaderLocation:  Thousand Oaks (northwest Los Angeles area), CAReports to:  Director, External ManufacturingPrimary Responsibilities:Supports operations (technical, quality, supply chain, manufacturing) activities associated with the planning, manufacture and delivery of products at CMOs and partners.Leads cross-functional initiatives that advance Atara’s manufacturingPartners with CMO to ensure successful manufacture of products required for clinical supply, process validation and/or commercial supply.Supports guidance for process validation activities at the contract manufacturing facility. Provides technical input to Process Sciences for defining the critical parameters of new processes and provides a manufacturing perspective to support batch record design, SOP instruction development and training material content determination.Collaborates with manufacturing quality partner and internal Atara quality teams to develop processes and systems that enable compliant, successful technology transfers, operation and lifecycle management of cGMP clinical and commercial manufacturing processes, ensuring all product delivery schedules are met.Provides technical depth to support troubleshooting efforts and leads high-level deviation investigations.Organizes and facilitates team meetings and presentations; generate meeting minutes and clearly identify and assign actions, due dates and dependencies.Drives timely decisions and facilitates active communication and information flow between contract manufacturer and Atara team members.Authors technical documents for regulatory agency submission in support of manufacturing processes and serves as process subject matter expert in health authority interactions.Identifies and drives process optimization initiatives and addresses opportunities for efficiency and capacity improvements.Partners with Process Sciences and Quality teams to identify and drive process optimization initiatives and address opportunities for efficiency and capacity improvements. Travel:  Domestic and international travel will be required (up to 75%)Physical Requirements: Subject to extended periods of sitting and/or standing, vision to monitor and moderate noise levels. Work is generally performed in an office or manufacturing environment.  Car and airplane travel is an essential part of the job.  Professional Qualifications:Strong communication skills (e.g., clear and concise), team player, proven negotiation skills.Excellent interpersonal skills with ability to lead, interact with, influence, resolve conflict and drive decisions among individuals from a variety of cultures and disciplines.Demonstrated track record of effective leadership and partnership in a contract manufacturing setting.Clear and concise communicator who is a team player and a proven negotiator.Expert problem-solver that leads with data, seeks subject matter expertise and is considerate of others point-of-view.Self-motivated, flexible and creative leader, able to prioritize, multi-task, and work in a fast-paced and demanding environment.Effective interpersonal skills as both a team leader and a team player.Strong leadership presence with ability to garner respect through sound technical analysis, business judgment and clear decision-making.Role model for Atara’s Values of patients first, innovation teamwork, community and mindset.Strong critical and logical thinking with ability to analyze problems, identify alternative solutions, and implement recommendations for resolution.Able to take ownership of a given assignment, proactively consulting other project team members and other department representatives for information or guidance, as necessary.Able to understand and interpret data/information and its practical application. Education and Professional Experience:Bachelors in a biological science (or more than 15 years of relevant experience) with 10 or more years of experience in biologics development including cell therapy development.Demonstrated experience supporting technology transfers, cGMP manufacturing operations and CMC regulatory submissions and inspections required.Fundamental knowledge in cell biology, cell culture, cell processing and cell cryopreservation principles.Breadth of knowledge across cell culture technologies, cell processing technologies, cell characterization methods, manufacturing under cGMP, validation, Quality Systems and regulatory requirements.Demonstrated in-depth skills in contract negotiation, budgeting and project management.More About Atara Bio:Now in our sixth year, we’re proud of our team of 260+ Atarians co-located by design in South San Francisco (corporate headquarters) and Southern California (R&D and manufacturing headquarters in the northwest Los Angeles area) with a newly-established European headquarters in Zug, Switzerland. Atara also has a R&D site in the Denver, Colorado area and an office in New York City. Our Southern California hub is anchored by a new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California.One mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork and expertise” – and a singular vision – “Cell therapy treatment for every patient, any time – provide inspiration and direction for all of us.”The Company's off-the-shelf, allogeneic T-cells are bioengineered from donors with healthy immune function and allow for rapid delivery from inventory to patients without a requirement for pretreatment. Atara's T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells.Atara's most advanced T-cell immunotherapy in development, tabelecleucel, or tab-cel™ (formerly known as ATA129), is being developed for the treatment of patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+ PTLD) who have failed rituximab, as well as other EBV-associated hematologic and solid tumors, including nasopharyngeal carcinoma (NPC). Tab-cel™ is in Phase 3 clinical development for the treatment of EBV+ PTLD following an allogeneic hematopoietic cell transplant (MATCH study) or solid organ transplant (ALLELE study).Atara is also developing off-the-shelf, allogeneic ATA188 and autologous ATA190 T-cell immunotherapies using a complementary targeted antigen recognition technology for specific EBV antigens believed to be important for the potential treatment of multiple sclerosis (MS). A Phase 1 clinical study of autologous ATA190 in patients with progressive MS is ongoing. Atara is also advancing a Phase 1 clinical study of ATA188 in patients with progressive or relapsing-remitting MS across clinical sites in the United States and Australia. Atara's clinical pipeline also includes ATA520 targeting Wilms Tumor 1 (WT1) and ATA230 directed against cytomegalovirus (CMV). Working at Atara BioPeople at Atara Bio are high integrity, roll-up-your-sleeves, get-it-done types who are keenly committed to putting patients first, advancing medical care and doing so with demonstrated urgency. At their core Atarians are people who work well with others and are “team-centric”, have purposeful curiosity and can’t wait to save patient lives. And similar to other biotech companies who have so many accomplished people, we expect humility (we are a “low hubris” sort of place), flexibility, respect, teamwork, good judgment and getting the most out of any dollar we spend. We also expect to enjoy the journey (and each other) as we move forward with a shared responsibility to teach and to learn from what we do and from our teammates.Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual’s association with a member of a protected group or connection to an organization or group related to a protected group.We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States. Apr 14th, 2019 11:12PM Apr 14th, 2019 11:12PM Health Care Pharmaceuticals & Biotechnology
7 nasdaq:atra www.atarabio.com www.atarabio.com Apr 15th, 2019 12:00AM QC Associate - Analytical (Cell Culture) - 3 positions Open Quality Assurance & Quality Control Thousand Oaks, CA, United States Thousand Oaks CA USA Apr 9th, 2019 12:00AM We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options. We’re named after Atara Ciechanover who suffered from cancer before passing away. We are considered a leading off-the-shelf T-cell immunotherapy company (Nasdaq ATRA) developing novel treatments for patients with cancer, autoimmune and viral diseases.Position Summary:This role supports manufacturing and technical operations by executing raw material, in-process, and final product release QC analytical assays. Emphasis is on cell-based bioassays including cell culture maintenance, cell count and viability measurement, cell proliferation and cytotoxicity assay using radioactive isotope or MTT. QC test methods also include product release assays such as visual inspection, mycoplasma test, endotoxin test, pH, osmolarity check. The QC Associate works within Atara QC Bioanalytical lab and will be expected to interact regularly with QA, regulatory, manufacturing, process development, and translational sciences. The selected individual will be expected to support technical transfer of assays from development into QC, participate in all assay validations, and perform routine GMP testing of clinical and commercial products in compliance with GMP regulations. This position supports the qualification and validation of all QC analytical activities necessary to qualify our new Thousand Oaks cell manufacturing facility.Reports to:  QC Manager – Bioanalytical QCLocation:  Thousand Oaks (NW Los Angeles), CaliforniaPrimary Responsibilities:Performs routine testing on raw materials, process intermediates, final products, stability samples and reference standards with emphasis on cell-based assay.Supports the qualification of a GMP compliant QC bioanalytical laboratory.Participates in the validation and technical transfer of all analytical methods.Help to draft method SOPs, stability protocols, and reference standard testing protocols, validation protocol and report as needed.Executes method validation protocols and writes validation reports.Supports QC- Analytical management during internal and external inspections and audits.Support nonconformance investigate, root cause analysis and implement solutions.Travel:  Up to 10%Physical Requirements:Subject to extended periods of sitting and/or standing in a laboratory environment. Ability to lift 50 lbs. and to work in BL2 laboratory required. Require handling radioactive isotope following safety guideline.Position Requirements:Experience in cell culture and bioassay is desired.knowledge of relevant regulations and FDA guidance is desired.Excellent verbal and written communication skills, good interpersonal skills required.Flexibility to work overtime, after hours and travel as required to accommodate the business needs.Must be able to work in controlled environments requiring special gowning for biosafety and radiation laboratories.Must enjoy working in a fast paced, highly dynamic environmentEducation and Professional Experience:Requires minimum a Bachelor’s Degree in Biochemistry, Molecular and Cellular Biology, Immunology, or Biology with 0 - 5 years of experience or an equivalent combination of education and experience.Experience in cell-based bioassay and cell culture is a plus.Quality control experience in the pharmaceutical industry supporting cGMP areas preferred.Experience in cGMP cell therapy manufacturing and/or testing facility is a plus.More About Atara Bio:Now in our sixth year, we’re proud of our team of 260+ Atarians co-located by design in South San Francisco (corporate headquarters) and Southern California (R&D and manufacturing headquarters in the northwest Los Angeles area) with a newly-established European headquarters in Zug, Switzerland. Atara also has a R&D site in the Denver, Colorado area and an office in New York City. Our Southern California hub is anchored by a new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California. One mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork and expertise” – and a singular vision – “Cell therapy treatment for every patient, any time – provide inspiration and direction for all of us.”The Company's off-the-shelf, allogeneic T-cells are bioengineered from donors with healthy immune function and allow for rapid delivery from inventory to patients without a requirement for pretreatment. Atara's T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells.Atara's most advanced T-cell immunotherapy in development, tabelecleucel, or tab-cel™ (formerly known as ATA129), is being developed for the treatment of patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+ PTLD) who have failed rituximab, as well as other EBV-associated hematologic and solid tumors, including nasopharyngeal carcinoma (NPC). Tab-cel™ is in Phase 3 clinical development for the treatment of EBV+ PTLD following an allogeneic hematopoietic cell transplant (MATCH study) or solid organ transplant (ALLELE study).Atara is also developing off-the-shelf, allogeneic ATA188 and autologous ATA190 T-cell immunotherapies using a complementary targeted antigen recognition technology for specific EBV antigens believed to be important for the potential treatment of multiple sclerosis (MS). A Phase 1 clinical study of autologous ATA190 in patients with progressive MS is ongoing. Atara is also advancing a Phase 1 clinical study of ATA188 in patients with progressive or relapsing-remitting MS across clinical sites in the United States and Australia. Atara's clinical pipeline also includes ATA520 targeting Wilms Tumor 1 (WT1) and ATA230 directed against cytomegalovirus (CMV). Working at Atara Bio:People at Atara Bio are high integrity, roll-up-your-sleeves, get-it-done types who are keenly committed to putting patients first, advancing medical care and doing so with demonstrated urgency. At their core Atarians are people who work well with others and are “team-centric”, have purposeful curiosity and can’t wait to save patient lives. And similar to other biotech companies who have so many accomplished people, we expect humility (we are a “low hubris” sort of place), flexibility, respect, teamwork, good judgment and getting the most out of any dollar we spend. We also expect to enjoy the journey (and each other) as we move forward with a shared responsibility to teach and to learn from what we do and from our teammates.Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual’s association with a member of a protected group or connection to an organization or group related to a protected group.We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States. Apr 14th, 2019 11:12PM Apr 14th, 2019 11:12PM Health Care Pharmaceuticals & Biotechnology
8 nasdaq:atra www.atarabio.com www.atarabio.com Apr 15th, 2019 12:00AM Senior Medical Science Liaison Open Medical Affairs Thousand Oaks, CA, United States Thousand Oaks CA USA Mar 18th, 2019 12:00AM We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options. We’re named after Atara Ciechanover who suffered from cancer before passing away. We are considered a leading off-the-shelf T-cell immunotherapy company (Nasdaq ATRA) developing novel treatments for patients with cancer, autoimmune and viral diseases.Position SummaryAtara Bio seeks a dedicated Sr. Medical Science Liaison (MSL) to join a newly formed field team in our growing Medical Affairs organization.  MSLs have the opportunity to work with a new cellular based therapeutic platform providing scientific education to healthcare providers in the transplant space.  Initial responsibilities include clinical trial site support and scientific exchange with key opinion leaders and relevant health care providers on Atara related products.  Later stage work includes pre-launch and launch related activities for lead product line in anticipation for full commercialization.      Reports to       Senior Director, North American MSLsLocation           Field-based, variable; Northeast preferredPosition ResponsibilitiesEstablishes and maintains relationships with target health care professionals:Scientific exchange with National and Regional thought leaders.Builds relationships with key HCP and Scientists.Participates and represents Atara at various scientific/cooperative group meetings.Participates in the identification and completion of clinical trials:Works with investigators and/or Atara study coordinators to maximize enrollment in Atara-sponsored clinical trials.Participates in the education of healthcare professionals and Atara employees:Participates in the training of healthcare professionals in the use of Atara product(s).Pending commercialization, serves as a resource in the education of sales, marketing and other internal functions.Participates in the identification and publication of scientific materials.Travel           Travel required (up to 75%)Physical RequirementsSubject to extended periods of sitting and/or standing, and vision to monitor. Work is generally performed in an office or clinical environment. Car and airplane travel is an essential part of the role. Position RequirementsEducation:  Advanced degree (MD, Pharm D, or PhD) required  Experience and Skills: Required: minimum 2 years of experience as a field MSL.Demonstrative therapeutic experience/research or substantive patient care experience is required.Medical, clinical or research experience in transplant/oncology is preferred.Ability to demonstrate expertise of key skills, capabilities and competencies.Role model for Atara’s Values of patients first, innovation teamwork, community and mindset.More About Atara BioNow in our sixth year, we’re proud of our team of 260+ Atarians co-located by design in South San Francisco (corporate headquarters) and Southern California (R&D and manufacturing headquarters in the northwest Los Angeles area) with a newly-established European headquarters in Zug, Switzerland. Atara also has a R&D site in the Denver, Colorado area and an office in New York City. Our Southern California hub is anchored by a new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California.One mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork and expertise” – and a singular vision – “Cell therapy treatment for every patient, any time – provide inspiration and direction for all of us.”The Company's off-the-shelf, allogeneic T-cells are bioengineered from donors with healthy immune function and allow for rapid delivery from inventory to patients without a requirement for pretreatment. Atara's T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells.Atara's most advanced T-cell immunotherapy in development, tabelecleucel, or tab-cel™ (formerly known as ATA129), is being developed for the treatment of patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+ PTLD) who have failed rituximab, as well as other EBV-associated hematologic and solid tumors, including nasopharyngeal carcinoma (NPC). Tab-cel™ is in Phase 3 clinical development for the treatment of EBV+ PTLD following an allogeneic hematopoietic cell transplant (MATCH study) or solid organ transplant (ALLELE study).Atara is also developing off-the-shelf, allogeneic ATA188 and autologous ATA190 T-cell immunotherapies using a complementary targeted antigen recognition technology for specific EBV antigens believed to be important for the potential treatment of multiple sclerosis (MS). A Phase 1 clinical study of autologous ATA190 in patients with progressive MS is ongoing. Atara is also advancing a Phase 1 clinical study of ATA188 in patients with progressive or relapsing-remitting MS across clinical sites in the United States and Australia. Atara's clinical pipeline also includes ATA520 targeting Wilms Tumor 1 (WT1) and ATA230 directed against cytomegalovirus (CMV). Working at Atara BioPeople at Atara Bio are high integrity, roll-up-your-sleeves, get-it-done types who are keenly committed to putting patients first, advancing medical care and doing so with demonstrated urgency. At their core Atarians are people who work well with others and are “team-centric”, have purposeful curiosity and can’t wait to save patient lives. And similar to other biotech companies who have so many accomplished people, we expect humility (we are a “low hubris” sort of place), flexibility, respect, teamwork, good judgment and getting the most out of any dollar we spend. We also expect to enjoy the journey (and each other) as we move forward with a shared responsibility to teach and to learn from what we do and from our teammates.Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual’s association with a member of a protected group or connection to an organization or group related to a protected group.We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States. Apr 14th, 2019 11:12PM Apr 14th, 2019 11:12PM Health Care Pharmaceuticals & Biotechnology
9 nasdaq:atra www.atarabio.com www.atarabio.com Apr 15th, 2019 12:00AM Senior Medical Science Liaison Open Medical Affairs New York City, NY, United States New York NY USA Mar 18th, 2019 12:00AM We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options. We’re named after Atara Ciechanover who suffered from cancer before passing away. We are considered a leading off-the-shelf T-cell immunotherapy company (Nasdaq ATRA) developing novel treatments for patients with cancer, autoimmune and viral diseases.Position SummaryAtara Bio seeks a dedicated Sr. Medical Science Liaison (MSL) to join a newly formed field team in our growing Medical Affairs organization.  MSLs have the opportunity to work with a new cellular based therapeutic platform providing scientific education to healthcare providers in the transplant space.  Initial responsibilities include clinical trial site support and scientific exchange with key opinion leaders and relevant health care providers on Atara related products.  Later stage work includes pre-launch and launch related activities for lead product line in anticipation for full commercialization.      Reports to       Senior Director, North American MSLsLocation           Field-based, variable; Northeast preferredPosition ResponsibilitiesEstablishes and maintains relationships with target health care professionals:Scientific exchange with National and Regional thought leaders.Builds relationships with key HCP and Scientists.Participates and represents Atara at various scientific/cooperative group meetings.Participates in the identification and completion of clinical trials:Works with investigators and/or Atara study coordinators to maximize enrollment in Atara-sponsored clinical trials.Participates in the education of healthcare professionals and Atara employees:Participates in the training of healthcare professionals in the use of Atara product(s).Pending commercialization, serves as a resource in the education of sales, marketing and other internal functions.Participates in the identification and publication of scientific materials.Travel           Travel required (up to 75%)Physical RequirementsSubject to extended periods of sitting and/or standing, and vision to monitor. Work is generally performed in an office or clinical environment. Car and airplane travel is an essential part of the role. Position RequirementsEducation:  Advanced degree (MD, Pharm D, or PhD) required  Experience and Skills: Required: minimum 2 years of experience as a field MSL.Demonstrative therapeutic experience/research or substantive patient care experience is required.Medical, clinical or research experience in transplant/oncology is preferred.Ability to demonstrate expertise of key skills, capabilities and competencies.Role model for Atara’s Values of patients first, innovation teamwork, community and mindset.More About Atara BioNow in our sixth year, we’re proud of our team of 260+ Atarians co-located by design in South San Francisco (corporate headquarters) and Southern California (R&D and manufacturing headquarters in the northwest Los Angeles area) with a newly-established European headquarters in Zug, Switzerland. Atara also has a R&D site in the Denver, Colorado area and an office in New York City. Our Southern California hub is anchored by a new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California.One mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork and expertise” – and a singular vision – “Cell therapy treatment for every patient, any time – provide inspiration and direction for all of us.”The Company's off-the-shelf, allogeneic T-cells are bioengineered from donors with healthy immune function and allow for rapid delivery from inventory to patients without a requirement for pretreatment. Atara's T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells.Atara's most advanced T-cell immunotherapy in development, tabelecleucel, or tab-cel™ (formerly known as ATA129), is being developed for the treatment of patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+ PTLD) who have failed rituximab, as well as other EBV-associated hematologic and solid tumors, including nasopharyngeal carcinoma (NPC). Tab-cel™ is in Phase 3 clinical development for the treatment of EBV+ PTLD following an allogeneic hematopoietic cell transplant (MATCH study) or solid organ transplant (ALLELE study).Atara is also developing off-the-shelf, allogeneic ATA188 and autologous ATA190 T-cell immunotherapies using a complementary targeted antigen recognition technology for specific EBV antigens believed to be important for the potential treatment of multiple sclerosis (MS). A Phase 1 clinical study of autologous ATA190 in patients with progressive MS is ongoing. Atara is also advancing a Phase 1 clinical study of ATA188 in patients with progressive or relapsing-remitting MS across clinical sites in the United States and Australia. Atara's clinical pipeline also includes ATA520 targeting Wilms Tumor 1 (WT1) and ATA230 directed against cytomegalovirus (CMV). Working at Atara BioPeople at Atara Bio are high integrity, roll-up-your-sleeves, get-it-done types who are keenly committed to putting patients first, advancing medical care and doing so with demonstrated urgency. At their core Atarians are people who work well with others and are “team-centric”, have purposeful curiosity and can’t wait to save patient lives. And similar to other biotech companies who have so many accomplished people, we expect humility (we are a “low hubris” sort of place), flexibility, respect, teamwork, good judgment and getting the most out of any dollar we spend. We also expect to enjoy the journey (and each other) as we move forward with a shared responsibility to teach and to learn from what we do and from our teammates.Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual’s association with a member of a protected group or connection to an organization or group related to a protected group.We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States. Apr 14th, 2019 11:12PM Apr 14th, 2019 11:12PM Health Care Pharmaceuticals & Biotechnology
10 nasdaq:atra www.atarabio.com www.atarabio.com Apr 15th, 2019 12:00AM Product Team Leader (VP / Sr Director) Open Product Leadership South San Francisco, CA, United States South San Francisco CA USA Mar 18th, 2019 12:00AM We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options. We’re named after Atara Ciechanover who suffered from cancer before passing away. We are considered a leading off-the-shelf T-cell immunotherapy company (Nasdaq ATRA) developing novel treatments for patients with cancer, autoimmune and viral diseases.Position SummaryReporting to the VP, Global Product Leadership, the Product Team Leader will be responsible for leading an interdisciplinary group in driving the formulation and execution of the plan for the global development and commercialization of a product. She/He will also be responsible for driving the execution of deliverables across all functional areas involved in the product team.Located at either Atara’s South San Francisco or Westlake Village office, the successful hire will:Reports to:        VP, Global Product LeadershipLocation:            Thousand Oaks (northwest LA area), CA or                             South San Francisco, CAPostion ResponsibilitiesLeads an interdisciplinary product team in driving the formulation and execution of the global development and commercialization plan.Responsible for a product’s overall strategic plan.Serves as the project champion and its chief advocate.Drives the decision-making process.Proactively identifies issues and drives for consensus and resolves conflict.Appropriately escalates issues to the executive team for action.Develops a tactical integrated project plan aligned to corporate goals and manages team members to achieve these goals.Ensures team focus and accountability to achieve goals.Actively partners with and leads all functional groups to ensure alignment and execution of the strategic development plan.Secures necessary resources for the team, including budget, and assures that the resources are utilized appropriately.Regularly interfaces with the Atara Bio Executive team, and any potential partners/collaborators, to recommend strategy and provide project updates.Provides input into team members’ performance feedback and objective achievements.Ensures that the project development plan is aligned with Atara’s mission for treating life threatening conditions that have been underserved by scientific innovation as well as Atara Bio’s values. Travel - Travel may be required (up to 20 depending on base location%).Physical RequirementsSubject to extended periods of sitting and/or standing, vision to monitor and moderate noise levels. Work is generally performed in an office environment. Car and airplane (see above) travel is an essential part of the job.Professional QualificationsThe candidate must have at least 15 years of experience in the biopharma industry and have seen the lifecycle of a pharmaceutical product.Demonstrated ability to lead cross functional product teams to develop and implement global development and commercialization strategies.Demonstrated multidisciplinary experience in drug development.Demonstrated ability to work successfully in a nimble, fast paced matrixed environment.Demonstrated ability to manage up and across an organization.B.S. Degree or higher, preferably in Life Sciences. Personal QualificationsSelf-organized, self-directed, highly motivated with strong critical thinking and analytical skills.Strong intellectual curiosity and rigor, and well-developed program and project management execution skills.Excellent communication and team management skills. Strong presentation skills.A collaborative team player who works and collaborates effectively with senior and junior colleagues.A confident and strategic individual who can think out loud and “brainstorm” in a collegial manner. Able to rapidly execute on agreed upon strategic and tactical plans.An innovative, data-driven and effective person with a “can do” attitude.A person who operates effectively in a small company and can manage across multiple time zones within a matrixed organization.A goal-oriented person who both plans for the long-term and executes for the short term.Role model for Atara’s Values of patients first, innovation teamwork, community and mindset.More About Atara BioNow in our sixth year, we’re proud of our team of 260+ Atarians co-located by design in South San Francisco (corporate headquarters) and Southern California (R&D and manufacturing headquarters in the northwest Los Angeles area) with a newly-established European headquarters in Zug, Switzerland. Atara also has a R&D site in the Denver, Colorado area and an office in New York City. Our Southern California hub is anchored by a new 90,000 sq. ft., state-of-the-art Atara T-Cell Operations and Manufacturing (ATOM) facility in Thousand Oaks, California.One mission – “Transform the lives of patients with serious medical conditions through pioneering science, teamwork and expertise” – and a singular vision – “Cell therapy treatment for every patient, any time – provide inspiration and direction for all of us.”The Company's off-the-shelf, allogeneic T-cells are bioengineered from donors with healthy immune function and allow for rapid delivery from inventory to patients without a requirement for pretreatment. Atara's T-cell immunotherapies are designed to precisely recognize and eliminate cancerous or diseased cells without affecting normal, healthy cells.Atara's most advanced T-cell immunotherapy in development, tabelecleucel, or tab-cel™ (formerly known as ATA129), is being developed for the treatment of patients with Epstein-Barr virus (EBV) associated post-transplant lymphoproliferative disorder (EBV+ PTLD) who have failed rituximab, as well as other EBV-associated hematologic and solid tumors, including nasopharyngeal carcinoma (NPC). Tab-cel™ is in Phase 3 clinical development for the treatment of EBV+ PTLD following an allogeneic hematopoietic cell transplant (MATCH study) or solid organ transplant (ALLELE study).Atara is also developing off-the-shelf, allogeneic ATA188 and autologous ATA190 T-cell immunotherapies using a complementary targeted antigen recognition technology for specific EBV antigens believed to be important for the potential treatment of multiple sclerosis (MS). A Phase 1 clinical study of autologous ATA190 in patients with progressive MS is ongoing. Atara is also advancing a Phase 1 clinical study of ATA188 in patients with progressive or relapsing-remitting MS across clinical sites in the United States and Australia. Atara's clinical pipeline also includes ATA520 targeting Wilms Tumor 1 (WT1) and ATA230 directed against cytomegalovirus (CMV). Working at Atara BioPeople at Atara Bio are high integrity, roll-up-your-sleeves, get-it-done types who are keenly committed to putting patients first, advancing medical care and doing so with demonstrated urgency. At their core Atarians are people who work well with others and are “team-centric”, have purposeful curiosity and can’t wait to save patient lives. And similar to other biotech companies who have so many accomplished people, we expect humility (we are a “low hubris” sort of place), flexibility, respect, teamwork, good judgment and getting the most out of any dollar we spend. We also expect to enjoy the journey (and each other) as we move forward with a shared responsibility to teach and to learn from what we do and from our teammates.Atara Bio is an equal opportunity employer and makes employment decisions on the basis of merit and other lawful factors. In accordance with applicable law, the Company prohibits discrimination based on race, color, religion, creed, sex, gender (including pregnancy, childbirth or medical condition related to pregnancy or childbirth), gender identity, expression or dysphoria, marital status, age, national origin or ancestry, physical or mental disability, medical condition, genetic information, veteran status, caregiver status, sexual orientation, transgender status or any other classification protected by federal, state or local laws or because of the individual’s association with a member of a protected group or connection to an organization or group related to a protected group.We comply with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Atara Bio in the United States. Apr 14th, 2019 11:12PM Apr 14th, 2019 11:12PM Health Care Pharmaceuticals & Biotechnology

Showing a preview of 42,677 records

Get a demo to see more examples from the Job Listings dataset.